Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202184881> ?p ?o ?g. }
- W3202184881 abstract "SUMMARY Despite remarkable clinical efficacies of immune checkpoint blockade (ICB) in cancer treatment, ICB benefits in triple-negative breast cancer (TNBC) remain limited. Through pooled in vivo CRISPR knockout (KO) screens in syngeneic TNBC mouse models, we found that inhibition of the E3 ubiquitin ligase Cop1 in cancer cells decreases the secretion of macrophage-associated chemokines, reduces tumor macrophage infiltration, and shows synergy in anti-tumor immunity with ICB. Transcriptomics, epigenomics, and proteomics analyses revealed Cop1 functions through proteasomal degradation of the C/ebpδ protein. Cop1 substrate Trib2 functions as a scaffold linking Cop1 and C/ebpδ , which leads to polyubiquitination of C/ebpδ . Cop1 inhibition stabilizes C/ebpδ to suppress the expression of macrophage chemoattractant genes. Our integrated approach implicates Cop1 as a target for improving cancer immunotherapy efficacy by regulating chemokine secretion and macrophage levels in the TNBC tumor microenvironment. Highlights Large-scale in vivo CRISPR screens identify new immune targets regulating the tumor microenvironment Cop1 knockout in cancer cells enhances anti-tumor immunity Cop1 modulates chemokine secretion and macrophage infiltration into tumors Cop1 targets C/ebp δ degradation via Trib2 and influences ICB response" @default.
- W3202184881 created "2021-10-11" @default.
- W3202184881 creator A5006519575 @default.
- W3202184881 creator A5013193636 @default.
- W3202184881 creator A5015323906 @default.
- W3202184881 creator A5018066077 @default.
- W3202184881 creator A5021521447 @default.
- W3202184881 creator A5022553634 @default.
- W3202184881 creator A5025010135 @default.
- W3202184881 creator A5030750380 @default.
- W3202184881 creator A5032987260 @default.
- W3202184881 creator A5033532061 @default.
- W3202184881 creator A5043946713 @default.
- W3202184881 creator A5044544424 @default.
- W3202184881 creator A5047841001 @default.
- W3202184881 creator A5050445993 @default.
- W3202184881 creator A5060700361 @default.
- W3202184881 creator A5065102493 @default.
- W3202184881 creator A5066070097 @default.
- W3202184881 creator A5071444129 @default.
- W3202184881 creator A5071821976 @default.
- W3202184881 creator A5084607092 @default.
- W3202184881 creator A5084985646 @default.
- W3202184881 date "2020-12-10" @default.
- W3202184881 modified "2023-09-27" @default.
- W3202184881 title "In Vivo CRISPR Screens Identify E3 Ligase Cop1 as a Modulator of Macrophage Infiltration and Cancer Immunotherapy Target" @default.
- W3202184881 cites W1016059894 @default.
- W3202184881 cites W1568317937 @default.
- W3202184881 cites W1665182114 @default.
- W3202184881 cites W1879165674 @default.
- W3202184881 cites W1897425543 @default.
- W3202184881 cites W1963904011 @default.
- W3202184881 cites W1964526894 @default.
- W3202184881 cites W1969951042 @default.
- W3202184881 cites W1971620413 @default.
- W3202184881 cites W1985987855 @default.
- W3202184881 cites W1987191607 @default.
- W3202184881 cites W2000179223 @default.
- W3202184881 cites W2000672459 @default.
- W3202184881 cites W2009046935 @default.
- W3202184881 cites W2009781189 @default.
- W3202184881 cites W2022996006 @default.
- W3202184881 cites W2026861011 @default.
- W3202184881 cites W2055620105 @default.
- W3202184881 cites W2060663588 @default.
- W3202184881 cites W2060972565 @default.
- W3202184881 cites W2072013301 @default.
- W3202184881 cites W2072319964 @default.
- W3202184881 cites W2074340664 @default.
- W3202184881 cites W2082850988 @default.
- W3202184881 cites W2085013798 @default.
- W3202184881 cites W2100122648 @default.
- W3202184881 cites W2101327682 @default.
- W3202184881 cites W2103441770 @default.
- W3202184881 cites W2108308200 @default.
- W3202184881 cites W2110266296 @default.
- W3202184881 cites W2117692326 @default.
- W3202184881 cites W2118278569 @default.
- W3202184881 cites W2118471749 @default.
- W3202184881 cites W2120772351 @default.
- W3202184881 cites W2127322768 @default.
- W3202184881 cites W2128723829 @default.
- W3202184881 cites W2134252799 @default.
- W3202184881 cites W2134526812 @default.
- W3202184881 cites W2140729960 @default.
- W3202184881 cites W2142604595 @default.
- W3202184881 cites W2159482845 @default.
- W3202184881 cites W2159522138 @default.
- W3202184881 cites W2161441477 @default.
- W3202184881 cites W2171808845 @default.
- W3202184881 cites W2179438025 @default.
- W3202184881 cites W2187414165 @default.
- W3202184881 cites W2201689894 @default.
- W3202184881 cites W2252568502 @default.
- W3202184881 cites W2261529227 @default.
- W3202184881 cites W2281046076 @default.
- W3202184881 cites W2299181842 @default.
- W3202184881 cites W2326425416 @default.
- W3202184881 cites W2341539131 @default.
- W3202184881 cites W2345415641 @default.
- W3202184881 cites W2402636472 @default.
- W3202184881 cites W2406478006 @default.
- W3202184881 cites W2507880739 @default.
- W3202184881 cites W2522313999 @default.
- W3202184881 cites W2528138045 @default.
- W3202184881 cites W2533508881 @default.
- W3202184881 cites W2544405043 @default.
- W3202184881 cites W2558219863 @default.
- W3202184881 cites W2559634823 @default.
- W3202184881 cites W2565479307 @default.
- W3202184881 cites W2580706718 @default.
- W3202184881 cites W2603969536 @default.
- W3202184881 cites W2608625783 @default.
- W3202184881 cites W2613155082 @default.
- W3202184881 cites W2613553789 @default.
- W3202184881 cites W2625817416 @default.
- W3202184881 cites W2736476343 @default.
- W3202184881 cites W2741508285 @default.
- W3202184881 cites W2749553776 @default.
- W3202184881 cites W2753291823 @default.